James Degar

3PUBLICATIONS
15CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jul 25, 2020
Exploiting the Therapeutic Interaction of WNT Pathway Activation and Asparaginase for Colorectal Cancer Therapy.

Laura Hinze, Roxane Labrosse, James Degar

|Nov 14, 2019
Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia.

Gayle P Pouliot, James Degar, Laura Hinze

|Nov 09, 2018
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia.

Ingrid M Ariës, Kimberly Bodaar, Salmaan A Karim

Pageof 1

Frequent Collaborators

2 joint publications

Alejandro Gutierrez

1 joint publications

Jack T Landrigan

1 joint publications

Sofie Peirs

1 joint publications

Björn Menten

1 joint publications

Donna S Neuberg

1 joint publications

Karen R Rabin

1 joint publications

Kimberly P Dunsmore

1 joint publications

Pieter Van Vlierberghe

1 joint publications

Stuart H Orkin

1 joint publications

Chau D Vo

Frequent Collaborators

2 joint publications

Alejandro Gutierrez

1 joint publications

Jack T Landrigan

1 joint publications

Sofie Peirs

1 joint publications

Björn Menten

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

14.2K
Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on : Aug 23, 2024

1.7K
<em>In Ovo</em> Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
06:48

<em>In Ovo</em> Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on : Aug 01, 2025

520
See more related videos

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

14.2K
Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on : Aug 23, 2024

1.7K
<em>In Ovo</em> Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
06:48

<em>In Ovo</em> Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on : Aug 01, 2025

520
See more related videos